510(k) Report

FDA applicant

Alere Scarborough, Inc.

Scarborough, ME17 decisions2012–20194 recalls

FDA records 17 decisions for Alere Scarborough, Inc. (Scarborough, ME) from 2012 to 2019: 16 510(k) clearances and 1 De Novo grant. Most are in product codes OCC (Respiratory Virus Panel Nucleic Acid Assay…) and PSZ (Devices Detecting Influenza A, B, And C Virus…). Since 2016 its 510(k)s took a median of 37 days from receipt to decision, against 113 for FDA’s reviews in the same codes and years. Its devices cite 20 predicates, 11 of them its own earlier devices. 4 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Alere Scarborough, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2019

2012: 12014: 22015: 32016: 32017: 32018: 32019: 2
2012high 3 (2015) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

1in 2026

2023: 12025: 22026 (partial year): 1
2012high 2 (2025) · low 0 (2012)2026

Class I Class II/III not classified

FIG. 1 — Alere Scarborough, Inc. by year, 2012–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Alere Scarborough, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Alere”

FDA records each applicant name separately; these may or may not be the same firm.